Literature DB >> 24062904

Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options.

Paolo Izzo1, Andrea Macchi, Luisa De Gennaro, Antonio Gaglione, Matteo Di Biase, Natale Daniele Brunetti.   

Abstract

Recurrent angina in patients who underwent percutaneous coronary intervention is defined as recurrence of chest pain or chest discomfort. Careful assessment is recommended to differentiate between non-cardiac and cardiac causes. In the case of the latter, recurrent angina occurrence can be related to structural ('stretch pain', in-stent restenosis, in-stent thrombosis, incomplete revascularization, progression of coronary atherosclerosis) or functional (coronary micro-vascular dysfunction, epicardial coronary spasm) causes. Even though a complete diagnostic algorithm has not been validated, ECG exercise testing, stress imaging and invasive assessment of coronary blood flow and coronary vaso-motion (i.e. coronary flow reserve, provocation testing for coronary spasm) may be required. When repeated coronary revascularization is not indicated, therapeutic approaches should aim at targeting the underlying mechanism for the patient's symptoms using a variety of drugs currently available such as beta-blockers, calcium-channel blockers, ivabradine or ranolazine.

Entities:  

Keywords:  Recurrent angina; coronary angioplasty

Year:  2012        PMID: 24062904      PMCID: PMC3760523          DOI: 10.1177/2048872612449111

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  124 in total

1.  Late survival and predictors of recurrent angina after coronary artery reoperation.

Authors:  D Dougenis; P J Kelly; A H Brown
Journal:  Thorac Cardiovasc Surg       Date:  1997-06       Impact factor: 1.827

2.  Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.

Authors:  Peter H Stone; Nikolay A Gratsiansky; Alexey Blokhin; I-Zu Huang; Lixin Meng
Journal:  J Am Coll Cardiol       Date:  2006-06-15       Impact factor: 24.094

3.  Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography.

Authors:  T Hozumi; K Yoshida; Y Ogata; T Akasaka; Y Asami; T Takagi; S Morioka
Journal:  Circulation       Date:  1998-04-28       Impact factor: 29.690

Review 4.  Treatment of refractory angina pectoris.

Authors:  Ramesh M Gowda; Ijaz A Khan; Gopikrishna Punukollu; Balendu C Vasavada; Chandra K Nair
Journal:  Int J Cardiol       Date:  2005-05-11       Impact factor: 4.164

5.  Angiographic and clinical characteristics of patients with acetylcholine-induced coronary vasospasm on follow-up coronary angiography following drug-eluting stent implantation.

Authors:  Shigenori Ito; Kosuke Nakasuka; Kotaro Morimoto; Masahiko Inomata; Takayuki Yoshida; Nozomu Tamai; Shin Suzuki; Yoshimasa Murakami; Akihiro Morino; Yoshiyuki Shimizu; Koichi Sato
Journal:  J Invasive Cardiol       Date:  2011-02       Impact factor: 2.022

6.  Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial.

Authors: 
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

Review 7.  Refractory angina pectoris: mechanism and therapeutic options.

Authors:  Michael C Kim; Annapoorna Kini; Samin K Sharma
Journal:  J Am Coll Cardiol       Date:  2002-03-20       Impact factor: 24.094

8.  Characteristics of a contemporary population with angina pectoris. TIDES Investigators.

Authors:  C J Pepine; J Abrams; R G Marks; J J Morris; S S Scheidt; E Handberg
Journal:  Am J Cardiol       Date:  1994-08-01       Impact factor: 2.778

9.  Nonischemic chest pain induced by coronary interventions: a prospective study comparing coronary angioplasty and stent implantation.

Authors:  A Jeremias; S Kutscher; M Haude; D Heinen; G Holtmann; W Senf; R Erbel
Journal:  Circulation       Date:  1998-12-15       Impact factor: 29.690

10.  Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.

Authors:  Kim Fox; Ian Ford; Ph Gabriel Steg; Michal Tendera; Michele Robertson; Roberto Ferrari
Journal:  Eur Heart J       Date:  2009-08-31       Impact factor: 29.983

View more
  10 in total

Review 1.  Prediction of Post Percutaneous Coronary Intervention Myocardial Ischaemia.

Authors:  Alda Huqi; Giacinta Guarini; Doralisa Morrone; Mario Marzilli
Journal:  Eur Cardiol       Date:  2016-12

2.  Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention.

Authors:  Yu Li; Fang Chen; Xiaoling Zhang; Yuechun Gao; Changyan Wu; Haiyan Li; Yuchen Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

3.  Machine Learning Identifies Metabolic Signatures that Predict the Risk of Recurrent Angina in Remitted Patients after Percutaneous Coronary Intervention: A Multicenter Prospective Cohort Study.

Authors:  Song Cui; Li Li; Yongjiang Zhang; Jianwei Lu; Xiuzhen Wang; Xiantao Song; Jinghua Liu; Kefeng Li
Journal:  Adv Sci (Weinh)       Date:  2021-03-08       Impact factor: 16.806

Review 4.  If Channel as an Emerging Therapeutic Target for Cardiovascular Diseases: A Review of Current Evidence and Controversies.

Authors:  Hayelom G Mengesha; Tadesse B Tafesse; Mohammed H Bule
Journal:  Front Pharmacol       Date:  2017-11-24       Impact factor: 5.810

5.  The risk for subsequent coronary interventions in a local Polish population.

Authors:  Jaroslaw Hiczkiewicz; Paweł Burchardt; Konrad Pieszko; Jan Budzianowski; Dariusz Hiczkiewicz; Bogdan Musielak; Anna Winnicka-Zielinska; Daria Adamczak; Wojciech Faron; Janusz Rzeźniczak
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-12-29       Impact factor: 1.426

6.  Ranolazine Versus Allopurinol for Eligible Symptomatic Patients With a History of Angioplasty: Comparative Efficacy Study.

Authors:  Reza Rahmani; Ehsan Moradi Farsani; Sima Bahrami
Journal:  Interact J Med Res       Date:  2022-08-17

7.  A novel method for measuring absolute coronary blood flow and microvascular resistance in patients with ischaemic heart disease.

Authors:  Paul D Morris; Rebecca Gosling; Iwona Zwierzak; Holli Evans; Louise Aubiniere-Robb; Krzysztof Czechowicz; Paul C Evans; D Rodney Hose; Patricia V Lawford; Andrew J Narracott; Julian P Gunn
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 13.081

8.  Angina self-management plan and quality of life, anxiety and depression in post coronary angioplasty patients.

Authors:  Marzieh Moattari; Fakhteh Adib; Javad Kojuri; Seyed Hamid Reza Tabatabaee
Journal:  Iran Red Crescent Med J       Date:  2014-11-09       Impact factor: 0.611

9.  Coronary magnetic resonance imaging after routine implantation of bioresorbable vascular scaffolds allows non-invasive evaluation of vascular patency.

Authors:  Constantin von Zur Mühlen; Simon Reiss; Axel J Krafft; Lisa Besch; Marius Menza; Manfred Zehender; Timo Heidt; Alexander Maier; Thomas Pfannebecker; Andreas Zirlik; Jochen Reinöhl; Peter Stachon; Ingo Hilgendorf; Dennis Wolf; Philipp Diehl; Tobias Wengenmayer; Ingo Ahrens; Christoph Bode; Michael Bock
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

10.  Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study.

Authors:  David Corcoran; Robin Young; David Adlam; Alex McConnachie; Kenneth Mangion; David Ripley; David Cairns; Julia Brown; Chiara Bucciarelli-Ducci; Andreas Baumbach; Rajesh Kharbanda; Keith G Oldroyd; Gerry P McCann; John P Greenwood; Colin Berry
Journal:  Int J Cardiol       Date:  2018-04-19       Impact factor: 4.164

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.